First Tracks Biotherapeutics reports positive ANB033 study results
The company announced positive top-line results for ANB033 in a gluten-challenge study in celiac disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.